Cargando…
A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633901/ https://www.ncbi.nlm.nih.gov/pubmed/35951168 http://dx.doi.org/10.1007/s40122-022-00413-w |
| _version_ | 1784824345078530048 |
|---|---|
| author | Liu, Xiaofen Hu, Jun Zhang, Ye |
| author_facet | Liu, Xiaofen Hu, Jun Zhang, Ye |
| author_sort | Liu, Xiaofen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9633901 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96339012022-12-07 A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Liu, Xiaofen Hu, Jun Zhang, Ye Pain Ther Letter Springer Healthcare 2022-08-10 2022-12 /pmc/articles/PMC9633901/ /pubmed/35951168 http://dx.doi.org/10.1007/s40122-022-00413-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Liu, Xiaofen Hu, Jun Zhang, Ye A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title | A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title_full | A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title_fullStr | A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title_full_unstemmed | A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title_short | A Response to: Letter to the Editor Regarding Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial |
| title_sort | response to: letter to the editor regarding preemptive intravenous nalbuphine for the treatment of post-operative visceral pain: a multicenter, double-blind, placebo-controlled, randomized clinical trial |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633901/ https://www.ncbi.nlm.nih.gov/pubmed/35951168 http://dx.doi.org/10.1007/s40122-022-00413-w |
| work_keys_str_mv | AT liuxiaofen aresponsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial AT hujun aresponsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial AT zhangye aresponsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial AT liuxiaofen responsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial AT hujun responsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial AT zhangye responsetolettertotheeditorregardingpreemptiveintravenousnalbuphineforthetreatmentofpostoperativevisceralpainamulticenterdoubleblindplacebocontrolledrandomizedclinicaltrial |